Signaling pathways and the fate of hepatic progenitor cells

信号通路和肝祖细胞的命运

基本信息

  • 批准号:
    7863457
  • 负责人:
  • 金额:
    $ 38.66万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-04-01 至 2014-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The ability of hepatic stem/progenitor cells to respond to severe liver injury is dependent upon a finely tuned balance of progenitor cell renewal, expansion and differentiation. In the liver, developmentally activated signaling pathways including the hedgehog, wnt and notch systems have been implicated in the regulation of hepatic progenitor cell renewal, tissue repair and the development of hepatocellular cancer. Until now, lack of specific genetic tools to modulate these pathways in adult hepatic progenitors has precluded the analysis of the specific contribution of these pathways to the progenitor cell response to liver injury. We have discovered that the winged helix transcription factor Foxl1 uniquely marks bipotential hepatic progenitor cells and have derived both Foxl1-Cre and tamoxifen inducible Foxl1-CreERT2 mouse strains to enable gain- and loss-of-function studies through the conditional deletion of individual components of the hedgehog, wnt and notch signaling pathways in hepatic progenitor cells. Using this approach, we will dissect the complex autocrine and paracrine signaling events that contribute to progenitor cell recruitment, differentiation and proliferation as well as paracrine effects on fibrogenesis during tissue repair in response to liver injury. We propose the existence of a signaling hierarchy in which the winged helix factor Foxl1 mediates the hedgehog and wnt/b-catenin signaling pathways necessary for progenitor cell renewal and proliferation. We predict that Notch acts downstream of wnt/b-catenin and promotes progenitor cell differentiation towards the biliary lineage and may also be required for biliary tubule morphogenesis. Understanding the biology of hepatic progenitor cells will have wide-ranging implications for the development of therapeutics for acute liver failure, chronic cirrhotic liver disease and hepatocellular carcinoma. PUBLIC HEALTH RELEVANCE: The studies proposed in this grant application will elucidate the signals that regulate hepatic progenitor cells and their response to acute or chronic liver injury. Understanding the biology of hepatic progenitor cells will have wide-ranging implications for the development of therapeutics for acute liver failure, chronic cirrhotic liver disease and hepatocellular carcinoma.
描述(由申请人提供):肝干/祖细胞对严重肝损伤做出反应的能力取决于祖细胞更新,扩张和分化的精细调整平衡。在肝脏中,包括刺猬,Wnt和Notch系统在内的发育激活的信号通路与肝祖细胞更新,组织修复和肝癌的发展有关。到目前为止,缺乏在成年肝祖细胞中调节这些途径的特定遗传工具排除了这些途径对祖细胞对肝损伤的特定贡献的分析。 We have discovered that the winged helix transcription factor Foxl1 uniquely marks bipotential hepatic progenitor cells and have derived both Foxl1-Cre and tamoxifen inducible Foxl1-CreERT2 mouse strains to enable gain- and loss-of-function studies through the conditional deletion of individual components of the hedgehog, wnt and notch signaling pathways in hepatic progenitor cells.使用这种方法,我们将剖析有助于祖细胞募集,分化和增殖的复杂自分泌和旁分泌信号事件,以及对肝损伤响应组织修复过程中纤维发生的影响。我们提出了一个信号层次结构的存在,其中有翼螺旋因子FOXL1介导刺猬和Wnt/b-catenin信号通路,用于祖细胞更新和增殖所必需的。我们预测Notch在Wnt/B-catenin的下游作用,并促进祖细胞分化向胆道谱系,也可能需要用于胆道小管形态发生。了解肝祖细胞的生物学将对急性肝衰竭,慢性肝硬化肝病和肝细胞癌癌的疗法发展具有广泛的影响。 公共卫生相关性:本赠款申请中提出的研究将阐明调节肝祖细胞的信号及其对急性或慢性肝损伤的反应。了解肝祖细胞的生物学将对急性肝衰竭,慢性肝硬化肝病和肝细胞癌癌的疗法发展具有广泛的影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Linda E GREENBAUM其他文献

Linda E GREENBAUM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Linda E GREENBAUM', 18)}}的其他基金

FASEB SRC on Liver Biology: Fundamental Mechanisms & Translational Application
FASEB SRC 肝脏生物学:基本机制
  • 批准号:
    8397455
  • 财政年份:
    2012
  • 资助金额:
    $ 38.66万
  • 项目类别:
Signaling pathways and the fate of hepatic progenitor cells
信号通路和肝祖细胞的命运
  • 批准号:
    8265850
  • 财政年份:
    2010
  • 资助金额:
    $ 38.66万
  • 项目类别:
Signaling pathways and the fate of hepatic progenitor cells
信号通路和肝祖细胞的命运
  • 批准号:
    8048131
  • 财政年份:
    2010
  • 资助金额:
    $ 38.66万
  • 项目类别:
Signaling pathways and the fate of hepatic progenitor cells
信号通路和肝祖细胞的命运
  • 批准号:
    8480398
  • 财政年份:
    2010
  • 资助金额:
    $ 38.66万
  • 项目类别:
Signaling pathways and the fate of hepatic progenitor cells
信号通路和肝祖细胞的命运
  • 批准号:
    8434170
  • 财政年份:
    2010
  • 资助金额:
    $ 38.66万
  • 项目类别:
Transcriptional control in hepatocyte proliferation
肝细胞增殖的转录控制
  • 批准号:
    7848538
  • 财政年份:
    2009
  • 资助金额:
    $ 38.66万
  • 项目类别:
Transcriptional Control in Hepatocyte Proliferation
肝细胞增殖的转录控制
  • 批准号:
    6524459
  • 财政年份:
    2001
  • 资助金额:
    $ 38.66万
  • 项目类别:
Transcriptional control in hepatocyte proliferation
肝细胞增殖的转录控制
  • 批准号:
    7800423
  • 财政年份:
    2001
  • 资助金额:
    $ 38.66万
  • 项目类别:
Transcriptional control in hepatocyte proliferation
肝细胞增殖的转录控制
  • 批准号:
    7589776
  • 财政年份:
    2001
  • 资助金额:
    $ 38.66万
  • 项目类别:
Transcriptional Control in Hepatocyte Proliferation
肝细胞增殖的转录控制
  • 批准号:
    6400608
  • 财政年份:
    2001
  • 资助金额:
    $ 38.66万
  • 项目类别:

相似国自然基金

玛纳斯河流域上游吸收性气溶胶来源及其对积雪消融的影响研究
  • 批准号:
    42307523
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
面向肝癌射频消融的智能建模与快速动力学分析方法研究及其临床验证
  • 批准号:
    62372469
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
IRF9调控CD8+T细胞介导微波消融联合TIGIT单抗协同增效抗肿瘤的作用机制
  • 批准号:
    82373219
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
建立可诱导细胞消融系统揭示成纤维细胞在墨西哥钝口螈肢体发育及再生中的作用
  • 批准号:
    32300701
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
肿瘤源PPIA介导结直肠癌肝转移射频消融术残瘤化疗抵抗的机制研究
  • 批准号:
    82302332
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Investigating cerebrovascular dysfunction and cerebral atrophy in severe traumatic brain injury
严重颅脑损伤中脑血管功能障碍和脑萎缩的调查
  • 批准号:
    10742569
  • 财政年份:
    2023
  • 资助金额:
    $ 38.66万
  • 项目类别:
Endothelial-Leukocyte Adhesion in CAR T Cell Treatment Associated Neurotoxicity
CAR T 细胞治疗相关神经毒性中的内皮-白细胞粘附
  • 批准号:
    10735681
  • 财政年份:
    2023
  • 资助金额:
    $ 38.66万
  • 项目类别:
Mechanisms Governing Uterine Epithelial Plasticity
子宫上皮可塑性的调控机制
  • 批准号:
    10710938
  • 财政年份:
    2023
  • 资助金额:
    $ 38.66万
  • 项目类别:
Improved arrhythmia ablation via MR-guided robotic catheterization and multimodal clinician feedback
通过 MR 引导的机器人导管插入术和多模式临床医生反馈改善心律失常消融
  • 批准号:
    10638497
  • 财政年份:
    2023
  • 资助金额:
    $ 38.66万
  • 项目类别:
Defining Astrocyte Engram Ensembles During Memory Formation
定义记忆形成过程中的星形胶质细胞印迹整体
  • 批准号:
    10722056
  • 财政年份:
    2023
  • 资助金额:
    $ 38.66万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了